Clinical Trial Update: A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 in Healthy Infants [Phase 2]

View source ↗

Summary

A Phase 2 clinical study to evaluate the safety, tolerability, and immunogenicity of the VAX-31 pneumococcal vaccine in healthy infants, with the trial status l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Disease

Drugs mentioned

• VAX-31 (31-valent pneumococcal conjugate vaccine)

Snippet

Sponsor: Vaxcyte, Inc. | Conditions: Pneumococcal Vaccines | Phase 2 | Status: ACTIVE_NOT_RECRUITING